Legent Imaging Increases Revenue, Decreases Rejected Claims

Konica Minolta Healthcare Americas, Inc. announced today the implementation of Exa® PACS/RIS/Billing and the company’s Revenue Cycle Management (RCM) solution, provided by All Covered, Konica Minolta Business Solutions U.S.A., Inc.'s IT Services Division, at Legent...

Stryker Launches Q Guidance System with Spine Guidance Software

Stryker has unveiled its Q Guidance System for spine applications. The system combines new optical tracking options provided by a redesigned, state-of-the-art camera with sophisticated algorithms of the newly launched Spine Guidance Software to deliver more surgical...

FDA Approves Gadopiclenol Injection for U.S. Market

Bracco Diagnostics Inc., the United States (U.S.) subsidiary of Bracco Imaging S.p.A., an innovative world leader in diagnostic imaging, announced that the U.S. Food and Drug Administration (FDA) has approved Gadopiclenol Injection, a new, highly stable macrocyclic...

Fujifilm Upgrades ASGE’s Institute for Training and Technology with State-of-the-Art Endoscopic Imaging Solutions

FUJIFILM Healthcare Americas Corporation and the American Society for Gastrointestinal Endoscopy (ASGE) announce that ASGE has equipped its Chicago-based Institute for Training and Technology (IT&T) Advanced Bioskills Laboratory and Simulation Center with 16 of...

Butterfly Files Motion to Dismiss Claims in FUJIFILM Sonosite Legal Action

Butterfly Network Butterfly iQ+

Butterfly Network Inc. has filed a motion to dismiss claims and specific patents from a complaint for patent infringement lawsuit filed on March 9, 2022, by FUJIFILM Sonosite Inc. Butterfly believes the lawsuit alleging infringement of U.S. Patent Nos. 7,169,108; 7,867,168; 8,128,050; 8,861,822; 9,538,985; 6,901,157; and 8,360,981, lacks merit and is meant to distract from FUJIFILM Sonosite’s failure to innovate and keep pace with Butterfly’s next generation clinical assessment platform.

Butterfly is shifting the health care industry from using ultrasound only in limited traditional settings, to using ultrasound information in all care settings, for any patient, and at any time, according to a news release. The company’s innovations include Butterfly iQ and iQ+, the world’s first handheld, single probe whole-body ultrasound system using semiconductor technology that is transforming point of care ultrasound into an advanced clinical assessment tool, by making it intuitive, adoptable at scale, extremely portable, and economically appealing.

Butterfly will vigorously defend against FUJIFILM Sonosite’s accusations, the release states. In defending against this lawsuit, Butterfly will consider all means necessary and appropriate to eliminate obstacles to its mission to enable more informed clinical decisions for all patients worldwide.

Butterfly’s Senior Vice President and Chief Legal Officer Larry Weiss said, “We’re disappointed that FUJIFILM Sonosite chose this approach. We believe this litigation is an attempt by FUJIFILM Sonosite Inc. to distract from its failure to innovate and keep pace with Butterfly’s next generation clinical assessment platform. Our state-of-the-art technology is the result of years of innovation and is evidenced by our more than 800 patents and applications. We will continue to vigorously protect both our innovations and our intellectual property.”



Submit a Comment

Your email address will not be published.